Siemens Healthineers (XTRA:SHL) Reports Strong Earnings Growth, Acquires Novartis Imaging Business [Yahoo! Finance]
SIEMENS AG SPONS ADR (SIEGY)
NASDAQ:AMEX Investor Relations:
siemens.com/investor
Company Research
Source: Yahoo! Finance
2024, reflecting the company's effective business strategies and market position. Despite facing challenges like a lower-than-expected return on equity and financial risks, the company's strategic acquisition of Novartis's molecular imaging business and focus on emerging markets signal promising growth prospects. This report will highlight key areas such as earnings growth, market positioning, and future strategies. See the full analysis report here for a deeper understanding of Siemens Healthineers. Siemens Healthineers has demonstrated impressive earnings growth, with a 28.7% increase over the past year, surpassing the industry average. This growth is supported by a net profit margin improvement from 7% to 8.7%, showcasing the company's financial health. Their stable dividend payments, covered by both earnings and cash flows, further underscore financial stability. The company's recent earnings report highlighted a year-over-year sales increase to €22.36 billion, with net income
Show less
Read more
Impact Snapshot
Event Time:
SIEGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIEGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIEGY alerts
High impacting SIEMENS AG SPONS ADR news events
Weekly update
A roundup of the hottest topics
SIEGY
News
- Cystatin C Assay Market Poised to Reach Over US$ 1.2 Billion by 2034, Driven by Advances in Renal Diagnostics | Transparency Market Research [Yahoo! Finance]Yahoo! Finance
- Isaac Ullatil Joins Wellstack Board of Directors [Yahoo! Finance]Yahoo! Finance
- Siemens Aktiengesellschaft (OTCMKTS: SIEGY) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating.MarketBeat
- ECHOLIGHT ANNOUNCES MULTI-YEAR AGREEMENT WITH SIEMENS HEALTHINEERS [Yahoo! Finance]Yahoo! Finance
- Optomec and Siemens Deliver Next Generation Manufacturing Solution for High Value Metal Repair [Yahoo! Finance]Yahoo! Finance
SIEGY
Analyst Actions
- 10/5/24 - Citigroup Inc.
SIEGY
Sec Filings
- 11/14/24 - Form 13F-HR
- 8/30/24 - Form N-PX
- SIEGY's page on the SEC website